Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $1.294B (100.0% shares, 0.0% debt)

Holdings (30)

LEGN LEGEND BIOTECH CORP 9.6%
Value $125M Shares 1,805,717 Est. Cost $48.56 Unrealized
INCY INCYTE CORP 6.6%
Value $86.01M Shares 1,381,711 Est. Cost $74.99 Unrealized -10.9%
IMCR IMMUNOCORE HLDGS PLC 5.9%
Value $76.16M Shares 1,270,124 Est. Cost $42.11 Unrealized
ACLX ARCELLX INC 5.7%
Value $74.21M Shares 2,347,000 Est. Cost $29.54 Unrealized +29.4%
KARUNA THERAPEUTICS INC 4.8%
Value $61.5M Shares 283,605 Est. Cost $216.85 Unrealized
CEREVEL THERAPEUTICS HLDNG I 4.6%
Value $59.41M Shares 1,868,946 Est. Cost $25.47 Unrealized
ARGX ARGENX SE 4.5%
Value $58.46M Shares 150,000 Est. Cost $375.49 Unrealized
VRDN VIRIDIAN THERAPEUTICS INC 4.4%
Value $57.46M Shares 2,415,256 Est. Cost $21.47 Unrealized +19.5%
ARGX ARGENX SE 4.3%
Value $55.44M Shares 142,259 Est. Cost $375.49 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 4.1%
Value $52.62M Shares 238,388 Est. Cost $214.96 Unrealized +3.0%
MIRATI THERAPEUTICS INC 4.0%
Value $52.16M Shares 1,443,762 Est. Cost $62.92 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 3.9%
Value $50.74M Shares 2,424,132 Est. Cost $21.25 Unrealized -2.0%
BCYC BICYCLE THERAPEUTICS PLC 3.9%
Value $50.67M Shares 1,985,430 Est. Cost $19.68 Unrealized
NUVL NUVALENT INC 3.7%
Value $47.25M Shares 1,120,465 Est. Cost $37.81 Unrealized 0.0%
ONC BEIGENE LTD 3.0%
Value $38.53M Shares 216,093 Est. Cost $210.00 Unrealized
XENE XENON PHARMACEUTICALS INC 2.9%
Value $38.09M Shares 989,327 Est. Cost $37.90 Unrealized +4.9%
OLMA OLEMA PHARMACEUTICALS INC 2.6%
Value $33.69M Shares 3,731,046 Est. Cost $4.79 Unrealized +26.1%
AMBRX BIOPHARMA INC 2.1%
Value $27.17M Shares 1,650,499 Est. Cost $16.46 Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 1.9%
Value $25.14M Shares 1,395,002 Est. Cost $19.24 Unrealized +3.6%
ALPINE IMMUNE SCIENCES INC 1.9%
Value $24.92M Shares 2,423,961 Est. Cost $7.85 Unrealized
VIR VIR BIOTECHNOLOGY INC 1.9%
Value $24.88M Shares 1,014,239 Est. Cost $25.11 Unrealized 0.0%
ZLAB ZAI LAB LTD 1.9%
Value $23.99M Shares 865,297 Est. Cost $31.19 Unrealized
IMTX IMMATICS N.V 1.8%
Value $22.9M Shares 1,984,813 Est. Cost $9.33 Unrealized 0.0%
AUTL AUTOLUS THERAPEUTICS PLC 1.7%
Value $21.94M Shares 9,217,150 Est. Cost $2.38 Unrealized
VOR BIOPHARMA INC 1.5%
Value $19.97M Shares 6,461,467 Est. Cost $6.84 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 1.5%
Value $19.64M Shares 85,000 Est. Cost $270.85 Unrealized 0.0%
VERONA PHARMA PLC 1.5%
Value $18.9M Shares 893,861 Est. Cost $20.08 Unrealized
MLTX MOONLAKE IMMUNOTHERAPEUTICS 1.5%
Value $18.85M Shares 369,615 Est. Cost $26.91 Unrealized 0.0%
THESEUS PHARMACEUTICALS INC 1.4%
Value $18.2M Shares 1,950,327 Est. Cost $8.98 Unrealized
KURA KURA ONCOLOGY INC 0.8%
Value $10.63M Shares 1,004,908 Est. Cost $11.83 Unrealized 0.0%